Interventions to improve the appropriate use of polypharmacy for older people

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Patterson, Susan M ^a   Hughes, Carmel ^a   Kerse, Ngaire ^b   Cardwell, Chris R ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

AGED; CLINICAL PROTOCOL; CLINICAL RESEARCH; DRUG RESEARCH; DRUG USE; ELDERLY CARE; HUMAN; PHARMACEUTICAL CARE; POLYPHARMACY; REVIEW;

EID: 77950150495     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008165     Document Type: Review

References (37)

1. Aronson 2004 Aronson JK, editor. In defence of polypharmacy. British Journal of Clinical Pharmacology 2004;57(2):119-20.
2. Barat 2001 Barat I, Andreasen F, Damsgaard EMS. Drug therapy in the elderly: what doctors believe and patients actually do. British Journal of Clinical Pharmacology 2001;51:615-22.
3. Barry 2007 Barry PJ, Gallagher P, Ryan C, O'Mahony D. START (screening tool to alert doctors to the right treatment) an evidence-based screening tool to detect prescribing omissions in elderly patients. Age and Ageing 2007;36(6):632-8.
4. Bedell 2000 Bedell SE, Jabbour S, Goldberg R, Glaser H, Gobble S, Young-Xu Y, et al.Discrepancies in the use of medications. Their extent and predictors in an outpatient practice. Archives of Internal Medicine 2000;160:2129-34.
5. Beers 1991 Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Archives of Internal Medicine 1991; 151:1825-32.
6. Beglinger 2008 Beglinger C. Ethics related to drug therapy in the elderly. Digestive Diseases 2008;26:28-31.
7. Bugeja 1997 Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997;315:1059.
8. Cowan 2002 Cowan D, While A, Roberts J, Fitzpatrick J. Medicines management in care homes for older people: the nurse's role. British Journal of Community Nursing 2002;7(12):634-8.
9. DoH 2001 Department of Health. National Service Framework for Older People. London 2001.
10. EPOC 2009 Effective Practice and Organisation of Care group. EPOC resources for review authors. http://www.epoc.cochrane.org/en/handsearchers.html (accessed May 05 2009).
11. Espino 1998 Espino DV, Lichtenstein LJ, Hazuda HP, Fabrizio D, Wood RC, Goodwin J, et al.Correlates of prescription and over-the-counter medication usage among older Mexican Americans: The Hispanic EPESE study. Journal of the American Geriatrics Society 1998;46 (10):1228-34.
12. Fick 2008 Fick DM, Mion LC, Beers MH, Waller JL. Health outcomes associated with potentially inappropriate medication use in older adults. Research in Nursing and Health 2008;31:42-51.
13. Fillenbaum 1996 Fillenbaum GG, Horner RD, Hanlon JT, Landerman LR, Dawson DV, Cohen HJ. Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population. Journal of Clinical Epidemiology 1996;49(5): 587-93.
14. Fulton 2005 Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. Journal of the American Academy of Nurse Practitioners 2005; 17(4):123-32.
15. Gallagher 2001 Gallagher LP. The potential for adverse drug reactions in elderly patients. Applied Nursing Research 2001;14(4):220-4.
16. Gallagher 2008 Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment). Consensus validation. International Journal of Clinical Pharmacology and Therapeutics 2008;46(2):72-83.
17. Gurwitz 2004 Gurwitz JH. Polypharmacy. A new paradigm for quality drug therapy in the elderly?. Archives of Internal Medicine 2004;164: 1957-9.
18. Hajar 2007 Hajar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. American Journal of Geriatric Psychiatry 2007;5(4): 345-51.
19. Higgins 2008 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions/http://www.cochrane.org/resources/ handbook. Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008.
20. Information Centre 2007 Information Centre (Health Care). Prescriptions dispensed in the community. Statistics for 1996-2006. England 2007.
21. JBS 2005 JBS 2: British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. Joint British Societies guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91((Suppl V)):v1-v52.
22. Jörgensen 2001 Jörgensen T, Johansson S, Kennerfalk A,Wallander M-A, Svärdsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Annals of Pharmacotherapy 2001;35:1004-9.
23. Kaufman 2002 Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287 (3):337-44.
24. Knight 2001 Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Annals of Internal Medicine 2001;135: 703-10.
25. Kuijpers 2007 Kuijpers MAJ, van Marum RJ, Egberts ACG, Jansen PAF, The OLDY (OLd people Drugs & dYsregulations) study group. Relationship between polypharmacy and underprescribing. British Journal of Clinical Pharmacology 2007;65(1):130-3.
26. Mangoni 2003 Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. British Journal of Clinical Pharmacology 2003;57:6-14.
27. Montamat 2004 Montamat SC, Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clinics in Geriatric Medicine 1992;8:143-58.
28. Philp 2007 Philp I. A recipe for care - not a single ingredient. Clinical case for change. Department of Health 2007.
29. Prybys 2002 Prybys KM. Polypharmacy in the elderly: clinical challenges in emergency practice. Part 1: Overview, etiology and drug interactions. Emergency Medicine Reports 2002;23(11):145-53.
30. RevMan 2008 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
31. Rollason 2003 Rollason V, Vogt N. Reduction of polypharmacy in the elderly. A systematic review of the role of the pharmacist. Drugs and Aging 2003;20(11):817-32.
32. Rossi 2007 Rossi MI, Young A, Maher R, Rodriguez KL, Appelt CJ, Perera S, et al.Polypharmacy and health beliefs in older outpatients. American Journal of Geriatric Pharmacotherapy 2007;5(4):317-23.
33. Simon 2005 Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, et al.Potentially inappropriate medication use by elderly persons in US health maintenance organizations, 2000-2001. Journal of the American Geriatrics Society 2005;53:227-32.
34. Steinman 2007 Steinman MA, editor. Polypharmacy and the balance of medication benefits and risks. American Journal of Geriatric Pharmacotherapy 2007;5(4):314-5.
35. Stewart 1990 Stewart RB. Polypharmacy in the elderly: a fait accompli?. Drug Intelligence and Clinical Pharmacy 1990;24:321-3.
36. Tamblyn 1996 Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. Canadian Medical Association Journal 1996;154(8):1177-84.
37. Werder 2003 Werder SF, Preskorn SH. Managing polypharmacy. Walking the fine line between help and harm. Current Psychiatry 2003;2(2): 24-36.